OncoMatch/Clinical Trials/NCT06712420
Neoadjuvant Chemotherapy for Locally Advanced Gall Bladder Cancer : a Randomized Control Trial (NEOGB)
Is NCT06712420 recruiting? Yes, currently enrolling (May 2026). This Phase 3 trial studies neoadjuvant chemotherapy for gall bladder carcinoma.
Phase 3RecruitingRajiv Gandhi Cancer Institute & Research Center, IndiaNCT06712420Data as of May 2026
Treatment: neoadjuvant chemotherapy — to study role of chemotherapy treatment for gall bladder cancer before surgery as compared to surgery directly
Check if I qualifyExtracted eligibility criteria
Cancer type
Urothelial Carcinoma
Performance status
ECOG 0–2(Ambulatory, capable of self-care)
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify